Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Direct Superior Approach Versus PosteroLateral Approach in Total Hip Arthroplasty: a Multicenter Double Blinded Randomized Controlled Trial

NCT06342843 is registered in ClinicalTrials.gov with Isala as lead sponsor.

NCT NCT06342843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06342843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Direct Superior Approach Versus PosteroLateral Approach in Total Hip Arthroplasty: a Multicenter Double Blinded Randomized Controlled Trial
Lead sponsor
Isala
Phase
Not applicable
Overall status
Recruiting
Start date
March 26, 2024
Completion date
December 31, 2027
Enrollment
211 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, hip